[Immunomodulating therapy with myelopid in experimental Salmonella infection].
The influence of myelopid on immunological characteristics in experimental Salmonella infection has been studied. This preparation has been found to produce a pronounced effect on the characteristics of immune response: it increases the number of T- and B-lymphocytes in the blood and the lymphoid organs. The indirect rosette-formation test has shown that myelopid facilitates earlier and more rapid binding and elimination of the antigen (S. typhimurium) from the body. Under the influence of myelopid the release of antigen-binding lymphocytes from the thymus to the peripheral lymphoid organs becomes more intensive.
Osmanova
L Ia
LIa
Gurariĭ
N I
NI
D028341:Activins; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000942:Antigens, Bacterial / Q000378:metabolism; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D004353:Drug Evaluation, Preclinical; D051379:Mice; D008810:Mice, Inbred C57BL; D009842:Oligopeptides; D010455:Peptides / Q000627:therapeutic use*; D012481:Salmonella Infections, Animal / Q000188:drug therapy* / Q000276:immunology; D012486:Salmonella typhimurium / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D009842:Oligopeptides; D010455:Peptides; C044147:activin B; D028341:Activins; C048617:myelopeptides
Immunomoduliruiushchaia terapiia mielopidom pri éksperimental'noĭ sal'monelleznoĭ infektsii.